or that i wrote the article. :)
i run the chasingthealpha.com blog and have since been brought in to help BMR with better coverage of small-cap biotech stocks and bring back some credibility. you can expect a lot more stories from me on BMR in the future.
i was behind the stories on AVNR, ALXA, DEPO, CLRT, CXM, SQNM and ARYX to name some recent ones.
unfortunately, i dont own any AYRX. i thought it was a well balanced article that expressed some optimism they could get a deal, but stressed they are low on cash and their leverage in any deal is not ideal.
Market Data 
Markets 
AI
